Form 4: Myomo Inc. Director Heather Getz Acquires RSUs

Heather Getz, a Director at Myomo, Inc., was granted Restricted Stock Units (RSUs) representing 78,704 shares of common stock, with vesting scheduled to begin in September 2026.

Summary

• Heather C. Getz, a Director at Myomo, Inc., received a grant of 78,704 Restricted Stock Units (RSUs) on June 25, 2026.
• These RSUs are part of the Issuer's 2018 Stock Option and Incentive Plan.
• Each RSU represents a contingent right to receive one share of Myomo, Inc. common stock.
• The RSUs will vest in four quarterly installments, starting on September 9, 2026.
• Ms. Getz has elected to defer the receipt of the common stock upon vesting until 30 days after termination of service or a change in control, whichever occurs first.
• Following this transaction, Ms. Getz beneficially owns 210,458 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports on a standard equity grant to a director rather than providing new financial performance data or strategic updates.

Positives

• Grant of equity awards (RSUs) to a Director, indicating alignment of management interests with shareholders.
• The grant is part of an established incentive plan, suggesting a structured approach to executive compensation.
• The reporting person already beneficially owns a significant number of shares (210,458), showing prior commitment to the company.

Negatives

• The RSUs are subject to vesting conditions and deferral elections, meaning the actual receipt of shares is not immediate.
• The filing does not provide details on the performance metrics or conditions tied to the RSU vesting beyond the scheduled installments.

Risks

• The value of the RSUs is subject to the future performance of Myomo, Inc.'s stock price.
• Vesting is contingent on continued service, meaning forfeiture is possible if service is terminated before vesting dates.
• The deferral election introduces a timing risk for Ms. Getz regarding when she will actually receive the shares.

Future Outlook

The filing primarily details a grant of equity awards and does not contain forward-looking financial guidance or projections for the company's future performance.

Industry Context

StockSavvy.ai notes that the grant of Restricted Stock Units (RSUs) to a director is a common practice in the biotechnology and medical device sectors, aiming to incentivize long-term performance and retention. This aligns with industry trends of using equity-based compensation to align executive interests with shareholder value.

Stakeholder Impact

• Shareholders: The grant aligns director incentives with long-term shareholder value, but the immediate impact on share price is minimal as it's a standard compensation event.
• Employees: The filing does not directly impact employees, but the incentive structure for leadership can indirectly influence company strategy and performance.
• Management: Heather Getz benefits from the potential future value of the RSUs, contingent on vesting and stock performance.

Next Steps

• Vesting of RSUs in quarterly installments beginning September 9, 2026.
• Potential receipt of common stock upon termination of service or change in control, subject to deferral election.

Key Dates

Keywords

Myomo Inc., MYO, Form 4, SEC Filing, Restricted Stock Units, RSU Grant, Director Compensation, Equity Awards, Beneficial Ownership, Stock Incentive Plan